Needle Biopsy Market Share, Growth And Trends Analysis By Type (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy) Utility (Disposable, Reusable), Applications (Tumor, Infection, Inflammation, Others) - Forecast Till 2030
ID: MRFR/MED/2542-HCR | 110 Pages | Published By Kinjoll Dey on April 2023
Table of Contents
1. INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2. RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3. MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4. MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL NEEDLE BIOPSY MARKET, BY TYPE
5.1 FINE-NEEDLE ASPIRATION BIOPSY
5.2 CORE NEEDLE BIOPSY
5.3 VACUUM-ASSISTED BIOPSY
5.4 IMAGE-GUIDED BIOPSY
6. GLOBAL NEEDLE BIOPSY MARKET, BY UTILITY
6.1 DISPOSABLE
6.2 REUSABLE
7. GLOBAL NEEDLE BIOPSY MARKET, BY APPLICATIONS
7.1 TUMOR
7.2 INFECTION
7.3 INFLAMMATION
7.4 OTHERS
8. GLOBAL NEEDLE BIOPSY MARKET, BY REGION
8.1 NORTH AMERICA
8.1.1 INTRODUCTION
8.2 EUROPE
8.2.1 INTRODUCTION
8.3 ASIA-PACIFIC
8.3.1 INTRODUCTION
8.4 MIDDLE EAST & AFRICA
8.4.1 INTRODUCTION
9. COMPETITIVE LANDSCAPE
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
9.1.1 STRATEGIC PARTNERSHIP
9.1.2 MERGER & ACQUISITION
10. COMPANY PROFILE
10.1 BOSTON SCIENTIFIC CORPORATION
10.1.1 OVERVIEW
10.1.2 PRODUCT OVERVIEW
10.1.3 FINANCIALS
10.1.4 KEY DEVELOPMENTS
10.2 COOK MEDICAL
10.2.1 OVERVIEW
10.2.2 PRODUCT OVERVIEW
10.2.3 FINANCIALS
10.2.4 KEY DEVELOPMENTS
10.3 CAREFUSION CORPORATION
10.3.1 OVERVIEW
10.3.2 PRODUCT OVERVIEW
10.3.3 FINANCIALS
10.3.4 KEY DEVELOPMENT
10.4 HOLOGIC, INC.
10.4.1 OVERVIEW
10.4.2 PRODUCT OVERVIEW
10.4.3 FINANCIALS
10.4.4 KEY DEVELOPMENTS
10.5 CARDINAL HEALTH, INC.
10.5.1 OVERVIEW
10.5.2 PRODUCT OVERVIEW
10.5.3 FINANCIALS
10.5.4 KEY DEVELOPMENTS
10.6 MEDAX
10.6.1 OVERVIEW
10.6.2 PRODUCT OVERVIEW
10.6.3 FINANCIALS
10.6.4 KEY DEVELOPMENTS
10.7 C. R. BARD
10.7.1 OVERVIEW
10.7.2 PRODUCT OVERVIEW
10.7.3 FINANCIALS
10.7.4 KEY DEVELOPMENTS
10.8 MÖLLER MEDICAL GMBH
10.8.1 OVERVIEW
10.8.2 PRODUCT OVERVIEW
10.8.3 FINANCIALS
10.8.4 KEY DEVELOPMENTS
10.10 BECTON, DICKINSON AND COMPANY
10.10.1 OVERVIEW
10.10.2 PRODUCT OVERVIEW
10.10.3 FINANCIALS
10.10.4 KEY DEVELOPMENTS
10.10 HAKKO CO. LTD.
10.10.1 OVERVIEW
10.10.2 PRODUCT OVERVIEW
10.10.3 FINANCIALS
10.10.4 KEY DEVELOPMENTS
10.11 KOMPASS
10.11.1 OVERVIEW
10.11.2 PRODUCT OVERVIEW
10.11.3 FINANCIALS
10.11.4 KEY DEVELOPMENTS
10.12 OTHERS
CONCLUSION
11.1 KEY FINDINGS
11.1.1 FROM CEO’S VIEWPOINT
11.1.2 UNMET NEEDS OF THE MARKET
11.2 KEY COMPANIES TO WATCH
11.3 PREDICTION OF NEEDLE BIOPSY INDUSTRY
12. APPENDIX
